GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shionogi & Co Ltd (TSE:4507) » Definitions » Cyclically Adjusted Revenue per Share

Shionogi (TSE:4507) Cyclically Adjusted Revenue per Share : 円1,169.36 (As of Dec. 2023)


View and export this data going back to 1949. Start your Free Trial

What is Shionogi Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Shionogi's adjusted revenue per share for the three months ended in Dec. 2023 was 円368.168. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is 円1,169.36 for the trailing ten years ended in Dec. 2023.

During the past 12 months, Shionogi's average Cyclically Adjusted Revenue Growth Rate was 7.10% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 4.20% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 3.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Shionogi was 4.20% per year. The lowest was 2.40% per year. And the median was 3.60% per year.

As of today (2024-04-27), Shionogi's current stock price is 円7306.00. Shionogi's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 was 円1,169.36. Shionogi's Cyclically Adjusted PS Ratio of today is 6.25.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Shionogi was 8.40. The lowest was 4.61. And the median was 6.41.


Shionogi Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Shionogi's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shionogi Cyclically Adjusted Revenue per Share Chart

Shionogi Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 947.71 973.82 978.05 1,016.57 1,100.91

Shionogi Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,091.40 1,100.91 1,124.15 1,152.50 1,169.36

Competitive Comparison of Shionogi's Cyclically Adjusted Revenue per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Shionogi's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shionogi's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shionogi's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Shionogi's Cyclically Adjusted PS Ratio falls into.



Shionogi Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Shionogi's adjusted Revenue per Share data for the three months ended in Dec. 2023 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=368.168/106.8000*106.8000
=368.168

Current CPI (Dec. 2023) = 106.8000.

Shionogi Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201403 213.781 95.700 238.577
201406 187.263 98.000 204.078
201409 200.256 98.500 217.130
201412 210.860 97.900 230.029
201503 222.974 97.900 243.244
201506 193.170 98.400 209.660
201509 225.039 98.500 244.002
201512 265.046 98.100 288.552
201603 254.283 97.900 277.400
201606 221.236 98.100 240.856
201609 247.826 98.000 270.080
201612 311.029 98.400 337.580
201703 254.319 98.100 276.873
201706 231.630 98.500 251.148
201709 299.982 98.800 324.272
201712 282.012 99.400 303.007
201803 254.528 99.200 274.028
201806 277.435 99.200 298.690
201809 250.247 99.900 267.531
201812 310.036 99.700 332.115
201903 329.404 99.700 352.862
201906 259.120 99.800 277.295
201909 265.751 100.100 283.539
201912 295.387 100.500 313.904
202003 258.174 100.300 274.905
202006 234.889 99.900 251.113
202009 248.274 99.900 265.422
202012 246.187 99.300 264.781
202103 239.870 99.900 256.438
202106 228.691 99.500 245.469
202109 252.396 100.100 269.290
202112 247.160 100.100 263.703
202203 383.013 101.100 404.607
202206 238.206 101.800 249.906
202209 262.491 103.100 271.911
202212 634.748 104.100 651.211
202303 300.052 104.400 306.950
202306 371.293 105.200 376.940
202309 413.993 106.200 416.332
202312 368.168 106.800 368.168

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Shionogi  (TSE:4507) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Shionogi's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=7306.00/1169.36
=6.25

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Shionogi was 8.40. The lowest was 4.61. And the median was 6.41.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Shionogi Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Shionogi's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Shionogi (TSE:4507) Business Description

Industry
Traded in Other Exchanges
Address
1-8, Doshomachi 3-chome, Chuo-ku, Osaka, JPN, 541-0045
Shionogi & Co Ltd is a specialty and generic drug manufacturing company. The company focuses on the manufacturing and distribution of pharmaceuticals, diagnostic reagents, and medical devices. Shionogi engages in manufacturing, formulation, packaging, and analysis as part of its commercialization research that spans late stage drug discovery through commercial production. The company's research and development strategy utilizes partnership and licensing opportunities with academic constituents and venture companies.

Shionogi (TSE:4507) Headlines

No Headlines